118 related articles for article (PubMed ID: 24518370)
1. Impact of ethnicity, gender, and dehydration on the urinary excretion of inhaled salbutamol with respect to doping control.
Dickinson J; Hu J; Chester N; Loosemore M; Whyte G
Clin J Sport Med; 2014 Nov; 24(6):482-9. PubMed ID: 24518370
[TBL] [Abstract][Full Text] [Related]
2. The influence of exercise and dehydration on the urine concentrations of salbutamol after inhaled administration of 1600 µg salbutamol as a single dose in relation to doping analysis.
Haase CB; Backer V; Kalsen A; Rzeppa S; Hemmersbach P; Hostrup M
Drug Test Anal; 2016 Jul; 8(7):613-20. PubMed ID: 26044066
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects.
Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Clin J Sport Med; 2012 Mar; 22(2):140-5. PubMed ID: 22388343
[TBL] [Abstract][Full Text] [Related]
4. Medical and pharmacological approach to adjust the salbutamol anti-doping policy in athletes.
Pillard F; Lavit M; Cances VL; Rami J; Houin G; Didier A; Rivière D
Respir Res; 2015 Dec; 16():155. PubMed ID: 26704899
[TBL] [Abstract][Full Text] [Related]
5. The enigma of inhaled salbutamol and sport: unresolved after 45 years.
Fitch KD
Drug Test Anal; 2017 Jul; 9(7):977-982. PubMed ID: 28294577
[TBL] [Abstract][Full Text] [Related]
6. Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations.
Eibye K; Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Med Sci Sports Exerc; 2013 Jan; 45(1):16-22. PubMed ID: 22843108
[TBL] [Abstract][Full Text] [Related]
7. Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes.
Hostrup M; Kalsen A; Auchenberg M; Rzeppa S; Hemmersbach P; Bangsbo J; Backer V
Drug Test Anal; 2014 Jun; 6(6):528-32. PubMed ID: 24166762
[TBL] [Abstract][Full Text] [Related]
8. Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control.
Ventura R; Segura J; Bergés R; Fitch KD; Morton AR; Berruezo S; Jiménez C
Ther Drug Monit; 2000 Jun; 22(3):277-82. PubMed ID: 10850394
[TBL] [Abstract][Full Text] [Related]
9. Inhaled salbutamol and doping control: effects of dose on urine concentrations.
Sporer BC; Sheel AW; Taunton J; Rupert JL; McKenzie DC
Clin J Sport Med; 2008 May; 18(3):282-5. PubMed ID: 18469572
[TBL] [Abstract][Full Text] [Related]
10. Urine concentrations of repetitive doses of inhaled salbutamol.
Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Int J Sports Med; 2011 Aug; 32(8):574-9. PubMed ID: 21563035
[TBL] [Abstract][Full Text] [Related]
11. Beta2-Agonist Doping Control and Optical Isomer Challenges.
Jacobson GA; Fawcett JP
Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
[TBL] [Abstract][Full Text] [Related]
12. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment.
Bergés R; Segura J; Ventura R; Fitch KD; Morton AR; Farré M; Mas M; de La Torre X
Clin Chem; 2000 Sep; 46(9):1365-75. PubMed ID: 10973867
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the urinary threshold concentration of formoterol in sports drug testing.
Ventura R; Damasceno LM; Ramírez R; Farré M; Bergés R; Segura J
Drug Test Anal; 2013 Apr; 5(4):266-9. PubMed ID: 23355217
[TBL] [Abstract][Full Text] [Related]
14. Determination of salbutamol and salbutamol glucuronide in human urine by means of liquid chromatography-tandem mass spectrometry.
Mareck U; Guddat S; Schwenke A; Beuck S; Geyer H; Flenker U; Elers J; Backer V; Thevis M; Schänzer W
Drug Test Anal; 2011; 3(11-12):820-7. PubMed ID: 22081503
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control.
Jessen S; Becker V; Rzeppa S; Backer V; Bengtsen KH; Hullstein I; Dehnes Y; Hostrup M
Drug Test Anal; 2021 Apr; 13(4):747-761. PubMed ID: 33210444
[TBL] [Abstract][Full Text] [Related]
16. The ergogenic effect of long-term use of high dose salbutamol.
Dickinson J; Molphy J; Chester N; Loosemore M; Whyte G
Clin J Sport Med; 2014 Nov; 24(6):474-81. PubMed ID: 24451697
[TBL] [Abstract][Full Text] [Related]
17. Terbutaline: level the playing field for inhaled β
Jacobson GA; Hostrup M
Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883
[TBL] [Abstract][Full Text] [Related]
18. Futility of current urine salbutamol doping control.
Heuberger JAAC; van Dijkman SC; Cohen AF
Br J Clin Pharmacol; 2018 Aug; 84(8):1830-1838. PubMed ID: 29722428
[TBL] [Abstract][Full Text] [Related]
19. Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control.
Jacobson GA; Hostrup M; Narkowicz CK; Nichols DS; Haydn Walters E
Drug Test Anal; 2017 Aug; 9(8):1262-1266. PubMed ID: 28033454
[TBL] [Abstract][Full Text] [Related]
20. Blood and urinary concentrations of salbutamol in asthmatic subjects.
Elers J; Pedersen L; Henninge J; Lund TK; Hemmersbach P; Dalhoff K; Backer V
Med Sci Sports Exerc; 2010 Feb; 42(2):244-9. PubMed ID: 19927035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
